Amgen Inc.
Amgen Inc. AMG.DE Peers
See (AMG.DE) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
---|---|---|---|---|---|---|
AMG.DE | €255.15 | +0.22% | 137.2B | 26.58 | €9.60 | +3.32% |
LLY.DE | €674.40 | +0.73% | 639.2B | 62.91 | €10.72 | +0.68% |
JNJ.DE | €135.84 | +1.15% | 326.8B | 17.30 | €7.85 | +3.04% |
4AB.DE | €167.20 | +1.46% | 295.3B | 81.56 | €2.05 | +3.17% |
ZEG.DE | €127.95 | +0.63% | 198.4B | 29.41 | €4.35 | +2.14% |
6MK.DE | €69.50 | +1.76% | 174.5B | 11.51 | €6.04 | +3.83% |
GIS.DE | €97.90 | -0.06% | 121.8B | 23.53 | €4.16 | +2.71% |
PFE.DE | €20.62 | +0.98% | 117.2B | 17.04 | €1.21 | +6.87% |
PFE.F | €20.59 | +1.58% | 117.1B | 17.16 | €1.20 | +6.88% |
SNW.DE | €88.43 | +1.09% | 107.7B | 17.72 | €4.99 | +4.43% |
Stock Comparison
AMG.DE vs LLY.DE Comparison
AMG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMG.DE stands at 137.2B. In comparison, LLY.DE has a market cap of 639.2B. Regarding current trading prices, AMG.DE is priced at €255.15, while LLY.DE trades at €674.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMG.DE currently has a P/E ratio of 26.58, whereas LLY.DE's P/E ratio is 62.91. In terms of profitability, AMG.DE's ROE is +0.66%, compared to LLY.DE's ROE of +0.77%. Regarding short-term risk, AMG.DE is more volatile compared to LLY.DE. This indicates potentially higher risk in terms of short-term price fluctuations for AMG.DE.
AMG.DE vs JNJ.DE Comparison
AMG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMG.DE stands at 137.2B. In comparison, JNJ.DE has a market cap of 326.8B. Regarding current trading prices, AMG.DE is priced at €255.15, while JNJ.DE trades at €135.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMG.DE currently has a P/E ratio of 26.58, whereas JNJ.DE's P/E ratio is 17.30. In terms of profitability, AMG.DE's ROE is +0.66%, compared to JNJ.DE's ROE of +0.30%. Regarding short-term risk, AMG.DE is more volatile compared to JNJ.DE. This indicates potentially higher risk in terms of short-term price fluctuations for AMG.DE.
AMG.DE vs 4AB.DE Comparison
AMG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMG.DE stands at 137.2B. In comparison, 4AB.DE has a market cap of 295.3B. Regarding current trading prices, AMG.DE is priced at €255.15, while 4AB.DE trades at €167.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMG.DE currently has a P/E ratio of 26.58, whereas 4AB.DE's P/E ratio is 81.56. In terms of profitability, AMG.DE's ROE is +0.66%, compared to 4AB.DE's ROE of +0.96%. Regarding short-term risk, AMG.DE is less volatile compared to 4AB.DE. This indicates potentially lower risk in terms of short-term price fluctuations for AMG.DE.
AMG.DE vs ZEG.DE Comparison
AMG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMG.DE stands at 137.2B. In comparison, ZEG.DE has a market cap of 198.4B. Regarding current trading prices, AMG.DE is priced at €255.15, while ZEG.DE trades at €127.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMG.DE currently has a P/E ratio of 26.58, whereas ZEG.DE's P/E ratio is 29.41. In terms of profitability, AMG.DE's ROE is +0.66%, compared to ZEG.DE's ROE of +0.19%. Regarding short-term risk, AMG.DE is more volatile compared to ZEG.DE. This indicates potentially higher risk in terms of short-term price fluctuations for AMG.DE.
AMG.DE vs 6MK.DE Comparison
AMG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMG.DE stands at 137.2B. In comparison, 6MK.DE has a market cap of 174.5B. Regarding current trading prices, AMG.DE is priced at €255.15, while 6MK.DE trades at €69.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMG.DE currently has a P/E ratio of 26.58, whereas 6MK.DE's P/E ratio is 11.51. In terms of profitability, AMG.DE's ROE is +0.66%, compared to 6MK.DE's ROE of +0.38%. Regarding short-term risk, AMG.DE is less volatile compared to 6MK.DE. This indicates potentially lower risk in terms of short-term price fluctuations for AMG.DE.
AMG.DE vs GIS.DE Comparison
AMG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMG.DE stands at 137.2B. In comparison, GIS.DE has a market cap of 121.8B. Regarding current trading prices, AMG.DE is priced at €255.15, while GIS.DE trades at €97.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMG.DE currently has a P/E ratio of 26.58, whereas GIS.DE's P/E ratio is 23.53. In terms of profitability, AMG.DE's ROE is +0.66%, compared to GIS.DE's ROE of +0.25%. Regarding short-term risk, AMG.DE is more volatile compared to GIS.DE. This indicates potentially higher risk in terms of short-term price fluctuations for AMG.DE.
AMG.DE vs PFE.DE Comparison
AMG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMG.DE stands at 137.2B. In comparison, PFE.DE has a market cap of 117.2B. Regarding current trading prices, AMG.DE is priced at €255.15, while PFE.DE trades at €20.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMG.DE currently has a P/E ratio of 26.58, whereas PFE.DE's P/E ratio is 17.04. In terms of profitability, AMG.DE's ROE is +0.66%, compared to PFE.DE's ROE of +0.09%. Regarding short-term risk, AMG.DE is less volatile compared to PFE.DE. This indicates potentially lower risk in terms of short-term price fluctuations for AMG.DE.
AMG.DE vs PFE.F Comparison
AMG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMG.DE stands at 137.2B. In comparison, PFE.F has a market cap of 117.1B. Regarding current trading prices, AMG.DE is priced at €255.15, while PFE.F trades at €20.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMG.DE currently has a P/E ratio of 26.58, whereas PFE.F's P/E ratio is 17.16. In terms of profitability, AMG.DE's ROE is +0.66%, compared to PFE.F's ROE of +0.09%. Regarding short-term risk, AMG.DE is less volatile compared to PFE.F. This indicates potentially lower risk in terms of short-term price fluctuations for AMG.DE.
AMG.DE vs SNW.DE Comparison
AMG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMG.DE stands at 137.2B. In comparison, SNW.DE has a market cap of 107.7B. Regarding current trading prices, AMG.DE is priced at €255.15, while SNW.DE trades at €88.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMG.DE currently has a P/E ratio of 26.58, whereas SNW.DE's P/E ratio is 17.72. In terms of profitability, AMG.DE's ROE is +0.66%, compared to SNW.DE's ROE of +0.08%. Regarding short-term risk, AMG.DE is more volatile compared to SNW.DE. This indicates potentially higher risk in terms of short-term price fluctuations for AMG.DE.
AMG.DE vs BRM.DE Comparison
AMG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMG.DE stands at 137.2B. In comparison, BRM.DE has a market cap of 86.4B. Regarding current trading prices, AMG.DE is priced at €255.15, while BRM.DE trades at €42.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMG.DE currently has a P/E ratio of 26.58, whereas BRM.DE's P/E ratio is 18.06. In terms of profitability, AMG.DE's ROE is +0.66%, compared to BRM.DE's ROE of +0.32%. Regarding short-term risk, AMG.DE is more volatile compared to BRM.DE. This indicates potentially higher risk in terms of short-term price fluctuations for AMG.DE.
AMG.DE vs BAYN.SG Comparison
AMG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMG.DE stands at 137.2B. In comparison, BAYN.SG has a market cap of 26B. Regarding current trading prices, AMG.DE is priced at €255.15, while BAYN.SG trades at €26.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMG.DE currently has a P/E ratio of 26.58, whereas BAYN.SG's P/E ratio is N/A. In terms of profitability, AMG.DE's ROE is +0.66%, compared to BAYN.SG's ROE of -0.08%. Regarding short-term risk, AMG.DE is less volatile compared to BAYN.SG. This indicates potentially lower risk in terms of short-term price fluctuations for AMG.DE.
AMG.DE vs BAYN.DE Comparison
AMG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMG.DE stands at 137.2B. In comparison, BAYN.DE has a market cap of 26B. Regarding current trading prices, AMG.DE is priced at €255.15, while BAYN.DE trades at €26.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMG.DE currently has a P/E ratio of 26.58, whereas BAYN.DE's P/E ratio is -7.96. In terms of profitability, AMG.DE's ROE is +0.66%, compared to BAYN.DE's ROE of -0.10%. Regarding short-term risk, AMG.DE is less volatile compared to BAYN.DE. This indicates potentially lower risk in terms of short-term price fluctuations for AMG.DE.
AMG.DE vs IDP.DE Comparison
AMG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMG.DE stands at 137.2B. In comparison, IDP.DE has a market cap of 17.1B. Regarding current trading prices, AMG.DE is priced at €255.15, while IDP.DE trades at €116.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMG.DE currently has a P/E ratio of 26.58, whereas IDP.DE's P/E ratio is 13.09. In terms of profitability, AMG.DE's ROE is +0.66%, compared to IDP.DE's ROE of +0.09%. Regarding short-term risk, AMG.DE is less volatile compared to IDP.DE. This indicates potentially lower risk in terms of short-term price fluctuations for AMG.DE.
AMG.DE vs GS7.DE Comparison
AMG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMG.DE stands at 137.2B. In comparison, GS7.DE has a market cap of 0. Regarding current trading prices, AMG.DE is priced at €255.15, while GS7.DE trades at €20.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMG.DE currently has a P/E ratio of 26.58, whereas GS7.DE's P/E ratio is 17.31. In terms of profitability, AMG.DE's ROE is +0.66%, compared to GS7.DE's ROE of +0.34%. Regarding short-term risk, AMG.DE is less volatile compared to GS7.DE. This indicates potentially lower risk in terms of short-term price fluctuations for AMG.DE.